New CDER appointee
This article was originally published in The Rose Sheet
Deborah Autor has been appointed as the director for the Center for Drug Evaluation & Research's Office of Compliance, CDER Director Steven Galson, MD, announces June 13. Autor has held the position of associate director for compliance policy since July 2002 after joining the Office as a senior advisor in October 2001. Her recent accomplishments included "reintegration of the Division of Scientific Investigations into the Office of Compliance," Galson explains. The previous acting director for CDER's compliance office, Joe Famulare, will take over as the Office's acting deputy director...
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.